Ouro Fino Saúde Animal Participações S.A. (BVMF:OFSA3)
Brazil · Delayed Price · Currency is BRL 21.42
+0.32 (1.52%)
At close: Aug 7, 2025, 4:55 PM GMT-3
Theseus Pharmaceuticals Cash Flow Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 130.88 | 134.33 | -49.98 | 130.66 | 113.96 | 89.72 | Upgrade |
Depreciation & Amortization | 28.46 | 27.89 | 26.92 | 24.41 | 20.49 | 18.4 | Upgrade |
Other Amortization | 11.48 | 11.48 | 9.27 | 8.06 | 13.01 | 25.76 | Upgrade |
Loss (Gain) From Sale of Assets | -1.47 | -1.49 | -0.79 | -2.98 | -2.55 | 2.7 | Upgrade |
Asset Writedown & Restructuring Costs | 4.09 | 4.84 | 21.68 | 0.91 | 0.68 | - | Upgrade |
Stock-Based Compensation | 12.24 | 7.2 | 9.64 | 8.1 | 0.48 | 0.15 | Upgrade |
Provision & Write-off of Bad Debts | -0.05 | -0.06 | 0.37 | -0.1 | -0.13 | 0.04 | Upgrade |
Other Operating Activities | 24.05 | 25.51 | 37.47 | 1.62 | -2.45 | 6.57 | Upgrade |
Change in Accounts Receivable | -38.3 | -87.09 | 38.64 | -57.2 | -36.19 | -19.46 | Upgrade |
Change in Inventory | -204.75 | -106.26 | 91.08 | -68.25 | -89.51 | -28.93 | Upgrade |
Change in Accounts Payable | 51.54 | 38.91 | -13.15 | 17.11 | 13.46 | 12.99 | Upgrade |
Change in Income Taxes | 5.52 | 0.02 | 37.32 | 14.08 | 2.46 | -0.46 | Upgrade |
Change in Other Net Operating Assets | 0.75 | 18.67 | -18.18 | 13.16 | 12.79 | 4.46 | Upgrade |
Operating Cash Flow | 24.43 | 73.94 | 190.3 | 89.59 | 46.5 | 111.94 | Upgrade |
Operating Cash Flow Growth | -83.99% | -61.15% | 112.41% | 92.67% | -58.46% | 98.51% | Upgrade |
Capital Expenditures | -25.41 | -17.8 | -24.92 | -51.97 | -55.91 | -15.25 | Upgrade |
Sale of Property, Plant & Equipment | 1.34 | 0.77 | 10.04 | 5.73 | 5.77 | 1 | Upgrade |
Cash Acquisitions | - | - | - | -14.53 | - | - | Upgrade |
Sale (Purchase) of Intangibles | -24 | -25.86 | -22.26 | -17.38 | -10.28 | -9.27 | Upgrade |
Investing Cash Flow | -48.06 | -42.88 | -37.14 | -78.15 | -60.41 | -23.53 | Upgrade |
Long-Term Debt Issued | - | 31.54 | 94.68 | 106.1 | 76.5 | 214 | Upgrade |
Total Debt Issued | 87.17 | 31.54 | 94.68 | 106.1 | 76.5 | 214 | Upgrade |
Long-Term Debt Repaid | - | -115.03 | -82.38 | -80.9 | -90.65 | -122.54 | Upgrade |
Total Debt Repaid | -102.09 | -115.03 | -82.38 | -80.9 | -90.65 | -122.54 | Upgrade |
Net Debt Issued (Repaid) | -14.92 | -83.49 | 12.31 | 25.2 | -14.15 | 91.46 | Upgrade |
Repurchase of Common Stock | -120.13 | - | - | - | -5.13 | - | Upgrade |
Common Dividends Paid | -18.17 | -18.17 | -23.41 | -33.22 | -35.61 | -10.99 | Upgrade |
Other Financing Activities | -1.9 | -0.51 | -3.25 | 0.07 | 4.26 | 11.05 | Upgrade |
Financing Cash Flow | -171.95 | -102.17 | -14.36 | -7.95 | -50.62 | 91.52 | Upgrade |
Foreign Exchange Rate Adjustments | -0.07 | 1.04 | 0.19 | 0.29 | 0.21 | 0.64 | Upgrade |
Net Cash Flow | -195.65 | -70.07 | 138.99 | 3.78 | -64.32 | 180.57 | Upgrade |
Free Cash Flow | -0.98 | 56.14 | 165.38 | 37.62 | -9.41 | 96.69 | Upgrade |
Free Cash Flow Growth | - | -66.06% | 339.66% | - | - | 354.84% | Upgrade |
Free Cash Flow Margin | -0.09% | 5.48% | 17.53% | 3.61% | -1.04% | 13.24% | Upgrade |
Free Cash Flow Per Share | -0.02 | 1.04 | 3.08 | 0.70 | -0.17 | 1.79 | Upgrade |
Cash Interest Paid | 30.1 | 30.1 | 34.89 | 34.56 | 19.11 | 12.76 | Upgrade |
Cash Income Tax Paid | 50.63 | 50.63 | 113.94 | 27.94 | 22.64 | 11.16 | Upgrade |
Levered Free Cash Flow | -41.83 | 63.5 | 152.73 | -42.8 | -68.13 | 83.81 | Upgrade |
Unlevered Free Cash Flow | -22.06 | 83.18 | 175.9 | -19.39 | -55.86 | 92.51 | Upgrade |
Change in Net Working Capital | 137.17 | 35.69 | -113.06 | 98.81 | 113.99 | 3.88 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.